We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Rise of high-tech instalment plans raise concerns about consumer repayments
The tech group may be a leader in the sector, but progress is slow-moving
Collapse in would-be buyer’s share price suggests the market thinks this deal will stay grounded
Members of the company’s founding family fight to uphold protections from $6bn opioid bankruptcy settlement in closely watched case
The essential factors we need to consider if the Federal Reserve chair is to get his wish
Swiss pharmaceutical group is under pressure to strengthen its pipeline of medicines
Use of technology to solve scientific problems still falls short of commercialisation
CFTC proposes standards for voluntary carbon credit derivatives
And private equity’s insurance trade
Three of the country’s biggest developers eye growth outside shrinking domestic market
Silicon Valley venture capital firms rush to establish ‘continuation funds’
Deal with Absci is the latest between big pharma and tech companies to build new disease treatments
Concerns about lower valuations and stringent listing requirements pushed management away from UK
Investors are rushing to take advantage of the highest yields in years before the Fed begins to cut interest rates
Plus, sportswear’s next frontier, why padel is the investor’s favourite pastime, and more
Tim Sloan claims he ‘bore the brunt of public criticism’ after scandals at the US bank
Breaking it down six different ways
Abu Dhabi-backed group is banned from controlling the newspaper while regulators scrutinise its bid
Investors should take heart from the cost savings now expected from the Bank of the West acquisition
Warren Buffett’s confidant would urge investors to focus on big tech’s fundamentals
Social media site accelerates plan to attract small businesses as billionaire owner battles big brands
Decision is setback for US drugmaker looking to increase sales after pandemic
Meme for sale, no previous owners
Plus, Peltz reignites proxy fight with Disney and Brookfield raises $30bn
Investors seeking shelter from inflation plough money into airports, toll roads and pipelines
International Edition
